Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

ALNYALNY
8 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ALNYLAM PHARMACEUTICALS INC

Yes. JPMorgan Chase holds 2,675,517 shares of ALNY (Alnylam Pharmaceuticals), worth $785.3M, as of its Q2 2026 13F filing. It reduced the position by 3,648,235 shares (-57.7%) from Q1 2026. JPMorgan Chase has held ALNY in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$785.3M

Current Shares

2.7M

Total Value Change

+$190.4M

Total Shares Change

+512,573

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.7M
-57.7%
$785.3M0.0%$301.03
0
2026-Q1
Increased
6.3M
+34.0%
$2B0.1%$330.87
49
2025-Q4
Increased
4.7M
+3.9%
$1.9B0.1%$397.65
40
2025-Q3
Increased
4.5M
+120.4%
$2.1B0.1%$456.00
62
2025-Q2
Decreased
2.1M
-7.1%
$672.4M0.0%$326.09
0
2025-Q1
Decreased
2.2M
-1.4%
$599.1M0.0%$270.02
0
2024-Q4
Increased
2.3M
+4.0%
$529.5M0.0%$235.31
33
2024-Q3
First report
2.2M
-
$594.9M0.0%$275.03
0

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used